3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
17
Carcinoma, Non-Small-Cell Lung
9
Triple Negative Breast Neoplasms
8
Lung Neoplasms
7
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Esophageal Squamous Cell Carcinoma
3
Stomach Neoplasms
2
Pancreatic Adenocarcinoma
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Advanced Solid Tumor
2
Uterine Cervical Neoplasms
1
Squamous Cell Non-small Cell Lung Cancer
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Neoplasms, Basal Cell
1
Muscle-Invasive Bladder Carcinoma
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Lymphoma
1
Locally Advanced or Metastatic Solid Tumors
1
Locally Advanced Pancreatic Cancer
1
Interventions
trastuzumab deruxtecan
1
taxane
1
sacituzumab govitecan
1
liposomal doxorubicin
1
eribulin
1
Vinorelbine
1
Paclitaxel
1
Gemcitabine
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Carboplatin
1
Capecitabine
1
Anthracyclines
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
HER2-negative Breast Cancer
×
Albumin-Bound Paclitaxel
×
Clear all
NCT06102824
2024-11-25
ORIENTA
Guangdong Provincial People's Hospital
Phase 2
Recruiting
252 enrolled